PatternsRadar
Sign in

SAILIFESai Life Sciences Limited

NSE
1,800.70INR+12.30 (+0.69%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹38,279 CrMarket cap
101.7P/E (TTM)
35.2%Delivery

Filings & corporate actions

8 results filed
CSV
Next results · Q3 FY27
Expected 5 Feb 2027 – 13 Feb 2027
Estimate: filed 36–44 days after quarter end, last 8 times
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone+12.0%NSE
  • 7 OctshareholdingShareholding · 30 Sept 2026+0.2%NSE
  • 6 AugresultsResults · Q1 FY27 · consolidated and standalone-3.4%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+2.0%NSE
  • 14 MayresultsResults · Q4 FY26 · consolidated and standalone-1.9%NSE
  • 14 AprshareholdingShareholding · 31 Mar 2026-0.9%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone+4.8%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-3.6%NSE

Reaction to results · all yearsrose on day 0 in 4 of 8 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+12.0%+21.0%—27.5×
Q1 FY276 Aug 2026-3.4%+2.6%+12.1%2.1×
Q4 FY2614 May 2026-1.9%+0.1%+8.6%11.5×
Q3 FY265 Feb 2026+4.8%+12.8%+25.4%10.6×
Q2 FY266 Nov 2025-5.1%-5.5%-5.0%3.1×
Q1 FY267 Aug 2025+4.6%+13.7%+8.1%8.0×
Q4 FY2514 May 2025+4.5%+2.1%+6.1%2.8×
Q3 FY257 Feb 2025-4.4%-11.1%-6.4%0.8×
Average+1.4%+4.5%+7.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+22.5%
Profit YoY+17.3%
Interest cost YoY-35.2%
Revenue QoQ+18.8%
Profit QoQ+34.2%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open1,780.00
Day range1,776.90 – 1,829.90
52-week range783.85 – 1,954.80
From 52w high-7.9%
RSI (14)61.7
ATR (14)77.09
Volume6.18L
Avg volume (20D)19.68L
Rel volume0.31×
Volatility (1Y)36.7%
Turnover₹111.5Cr
Traded value (NSE)₹111.5Cr
VWAP1,805.56
SMA 50 / 2001,588.15 / 1,262.58
Price band20%

Delivery percentage

Latest · 20 Nov 202635.2%
20-day avg41.8%
1-year avg52.3%
Percentile (own history)11th
Range8.5–90.0%
Sessions478

Over the last 20 sessions SAILIFE settled 41.8% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 52.3%, so recent sessions are running 10.5 points lower than usual. The latest session ranks higher than 11% of the 478 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders1.43L · +14.4% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy451 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.69%-6.64%+29.00%+22.36%+58.22%+106.51%

Valuation

Market cap₹38,279 Cr
Market cap (NSE)₹38,246 Cr
Free-float cap₹25,073 Cr
P/E (TTM)101.7
P/E (NSE)101.0
EPS (TTM)17.70
P/B14.2
Net margin (TTM)15.9%
Other income / PBT6.2%
ROE15.2%
Debt / equity0.17
Shares outstanding21.24Cr
Listed18 Dec 2024

Ownership

Promoter34.50%
Promoter Δ QoQ-0.03 pp
Public65.50%
FII19.91%
DII32.32%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)556.5602.1554.3658.6
YoY chg+26.5%+3.9%+11.7%+22.5%
Net profit (₹ Cr)100.4104.273.398.3
YoY chg+86.4%+18.1%+21.2%+17.3%
Net margin18.0%17.3%13.2%14.9%
EPS4.714.873.424.58

Shareholding over time

By quarter

30 Sept 2026 · promoter 34.50% · public 65.50%
16 Dec 2024: promoter 35.24%31 Dec 2024: promoter 35.24%31 Mar 2025: promoter 35.17%30 Jun 2025: promoter 35.15%30 Sept 2025: promoter 34.94%31 Dec 2025: promoter 34.70%31 Mar 2026: promoter 34.61%30 Jun 2026: promoter 34.53%30 Sept 2026: promoter 34.50%
2024-122026-09
  • Promoter
  • Public and others
Promoter
34.50%
Public
65.50%
Promoter change
-0.03 pp
Filed
7 Oct 2026
FII
19.91%
DII
32.32%
Promoter pledged
0.00%

Who the public is

Mutual funds
29.56%

+0.09 pp QoQ

Insurance
2.65%

-0.26 pp QoQ

FPI
19.91%

+0.26 pp QoQ

Retail ≤ ₹2L
5.03%

-0.07 pp QoQ

HNI > ₹2L
2.18%

+0.50 pp QoQ

NRI
3.43%

-0.50 pp QoQ

Bodies corporate
0.72%

+0.18 pp QoQ

Shareholders
1,43,124

+14.4% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
MYTREYI KANUMURI Partner of Marigold Partners (Partnership Firm)Promoter · Other10.44%
INVESCO INDIA FLEXI CAP FUNDMutual fund7.43%
RANGA RAJU KANUMURI Partner of Sunflower Partners (Partnership Firm)Promoter · Other7.34%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MULMutual fund6.79%
GOKARAJU SUBBA RAJUPromoter · Individual4.54%
MYTREYI KANUMURI Partner of Tulip Partners (Partnership Firm)Promoter · Other4.37%
RANGA RAJU KANUMURI Partner of Lily Partners (Partnership Firm)Promoter · Other3.25%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FMutual fund3.19%
ADITYA BIRLA SUN LIFE MUTUAL FUND - ADITYA BIRLA SMutual fund2.81%
SMALLCAP WORLD FUND, INCFPI2.57%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
1
1 open-market of the newest 1
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
26 Feb 2025TUNER GHOSHOtherSell71.1K₹5.1Cr713.075.75L → 5.04L0.24%-0.03 pp7(2)told 21 Feb 2025

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 30 Mar 2026

CSV
12 of 26 deals
By year
DateDealClientQuantityPriceValue
30 Mar 2026Sell · blockGOLDMAN SACHS BANK EUROPE SE - ODI7.97L1,015.40₹80.9Cr
30 Mar 2026Buy · blockMORGAN STANLEY ASIA SINGAPORE PTE7.97L1,015.40₹80.9Cr
18 Sept 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI6.02L898.50₹54.1Cr
18 Sept 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI6.02L898.50₹54.1Cr
17 Sept 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI4.01L881.35₹35.4Cr
17 Sept 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI4.01L881.35₹35.4Cr
16 Sept 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE - ODI2.75L882.00₹24.3Cr
16 Sept 2025Buy · blockGOLDMAN SACHS BANK EUROPE SE - ODI2.75L882.00₹24.3Cr
26 Aug 2025Sell · bulkTPG ASIA VII SF PTE LTD1.02Cr871.86₹892.4Cr
26 Aug 2025Sell · bulkTPG ASIA VII SF PTE LTD1.02Cr871.18₹891.7Cr
26 Aug 2025Sell · bulkTPG ASIA VII SF PTE LTD1.02Cr871.01₹891.5Cr
26 Aug 2025Buy · bulkSOCIETE GENERALE14.07L871.00₹122.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Price move > 100% in 1 year · since 18 Nov 2026 — One of the criteria NSE’s surveillance watches: price move > 100% in 1 year.
  • Price move > 25% in 1 month · since 11 Nov 2026 — One of the criteria NSE’s surveillance watches: price move > 25% in 1 month.
  • P/E > 50 (4 quarters) · since 19 Dec 2024 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations439.8579.5496.4537.5556.5602.1554.3658.6
Other income9.19.69.915.38.415.53.54.0
Total income448.9589.1506.3552.8564.8617.7557.8662.6
Total expenses377.2470.3425.6440.7422.4478.7459.9531.3
└ Finance costs23.110.912.49.49.77.87.610.9
└ Depreciation34.137.537.739.744.145.345.948.1
Profit before tax71.6118.880.7112.1134.2139.298.0131.3
Tax expense17.830.520.328.233.835.024.733.0
Net profit53.988.360.583.8100.4104.273.398.3
EPS2.894.242.904.014.774.933.464.63
Net margin12.25%15.23%12.18%15.60%18.04%17.31%13.22%14.93%
PBT margin16.29%20.50%16.27%20.85%24.11%23.12%17.68%19.93%
Tax rate24.84%25.70%25.13%25.17%25.19%25.13%25.20%25.11%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY25H1 FY26FY26H1 FY27
Total assets3,160.03,331.53,626.14,202.3
Current assets1,504.51,489.51,410.51,440.5
└ Cash & equivalents91.1207.781.930.9
└ Other bank balances372.898.529.028.6
└ Current investments0.00.047.048.5
└ Trade receivables354.8492.0373.6342.2
└ Inventories118.9122.2151.0242.0
Total equity2,128.42,269.72,483.72,688.1
└ Attributable to owners2,128.42,269.72,483.72,688.1
└ Share capital20.821.021.221.2
Borrowings128.6215.595.1448.2
└ Current128.6215.574.6417.9
└ Non-current0.00.020.530.3
Trade payables322.5244.9285.3272.8
Current liabilities732.5775.5833.71,184.8
Total liabilities1,031.61,061.81,142.51,514.2
Net debt(335.2)(90.7)(62.7)340.3
Debt / equity0.060.090.040.17
Current ratio2.051.921.691.22

Cash flow, year to date

 FY25H1 FY26FY26H1 FY27
Operating cash flow314.092.8509.1190.1
└ Capex(369.3)(247.6)(593.0)(561.3)
Free cash flow(55.2)(154.8)(83.8)(371.2)
Investing cash flow(536.7)(10.5)(395.4)(553.1)
Financing cash flow301.431.8(123.7)312.1
└ Dividends paid0.00.00.00.0
└ Buybacks0.00.00.00.0
Net change in cash79.1116.7(10.0)(51.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SAILIFE at a glance

  • SAILIFE closed at ₹1,800.7 on 20 Nov 2026, +0.69% on the day, +106.5% over one year, 7.9% below its 52-week high of ₹1,954.8.
  • Delivery was 35.2% of traded quantity on 20 Nov 2026, the 11th percentile of its own 478 sessions with a reading (20-session average 41.8%, 1-year average 52.3%).
  • Market capitalisation is ₹38,279 crore at a trailing P/E of 101.7 (trailing EPS ₹17.7).
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹659 crore (+22.5% year on year), net profit ₹98 crore (+17.3%); the price moved +12.0% on the first session after.
  • Promoters held 34.50% at 30 Sept 2026, down 0.03 percentage points on the previous filing.
  • Q3 FY27 results are expected between 5 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE570L01029
SeriesEQ
Listed18 Dec 2024
IPO price549.00 · band Rs.522 to Rs.549
IPO listing18 Dec 2024
NSE market cap · 17 Nov 2026₹37,234 Cr
Free-float market cap (NSE)₹24,182 Cr
Shares outstanding (NSE)21.26Cr
History from18 Dec 2024
Sessions478
Turnover rank#67

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.